Abrdn Life Sciences Investors

Informe acción NYSE:HQL

Capitalización de mercado: US$416.3m

Abrdn Life Sciences Investors Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Dan Omstead

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO23.8yrs
Participación del CEO0.7%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva18.8yrs

Actualizaciones recientes de la dirección

Recent updates

HQL: Hold Your Investments In This Healthcare CEF For Strong, Steady Yield

Sep 27

HQL: 13% Discount Creates An Opportunity

Jun 29

Tekla Life Sciences raises dividend by 6.5% to $0.33

Feb 15

Tekla Life Sciences declines quarterly dividend by -11.4% to $0.31/share

Nov 16

Tekla Life Sciences Investors: 10% Yield And Trading 10.5% Below NAV

Oct 23

HQL: A Biotechnology Equity CEF With No Leverage

Jul 12

HQL: Buy For The Yield, If You Can Stomach The Depreciation

Apr 27

Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend

Feb 11

Tekla Life Sciences Investors Rides Biotechnology Wave, Offers Growth With Steady Income

Sep 22

Evaluating Closed-End Funds: HQL Is Another Fine Pick In A Hot Sector

Jun 29

Tekla Life Sciences Investors: 8% Yield, 7% Discount

Jan 09

Tekla Life Sciences declares $0.02 special dividend

Dec 21

Tekla Life Sciences declares $0.40 dividend

Nov 16

CEO

Dan Omstead (71 yo)

23.8yrs

Permanencia

Dr. Daniel R. Omstead serves as Director at HotSpot Therapeutics, Inc. since April 2021. Dr. Omstead serves as the President since 2001, Chief Executive Officer, Chief Financial Officer, Manager, Trustee,...


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Daniel Omstead
Principal Executive Officer21.8yrssin datos0.72%
$ 3.0m
Michael Bonney
Trustee13.8yrsUS$26.50ksin datos
Oleg Pohotsky
Chairman24.8yrsUS$34.50ksin datos
Uwe Reinhardt
Independent Trustee32.8yrsUS$23.50ksin datos
William Reardon
Trustee14.8yrsUS$30.75ksin datos
Lucinda Stebbins
Independent Trustee18.8yrsUS$28.00ksin datos
Rakesh Jain
Trustee17.8yrsUS$24.00ksin datos
Rose DiMartino
Trusteeno datasin datos0.0037%
$ 15.2k

18.8yrs

Permanencia media

75.5yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de HQL son experimentados ( 18.8 años antigüedad media).